Author: Dyer, Wayne B; Zaunders, John J; Yuan, Fang Fang; Wang, Bin; Learmont, Jennifer C; Geczy, Andrew F; Saksena, Nitin K; McPhee, Dale A; Gorry, Paul R; Sullivan, John S
                    Title: Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection  Document date: 2008_12_11
                    ID: 0ddutmdd_9
                    
                    Snippet: When this prospective study began in 1994, 13 LTNP were identified in the NSW TAHIV cohort according to the original guidelines for classifying LTNP: at least 10 years infection, stable CD4 T cell counts >500 cells/μl, and no history of ART [27, 28] . Subsequently, loss of LTNP status was defined by any of the following events: a consistent decline in CD4 T cell counts below 500/μl, commencement of ART, and after viral load testing became routi.....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: When this prospective study began in 1994, 13 LTNP were identified in the NSW TAHIV cohort according to the original guidelines for classifying LTNP: at least 10 years infection, stable CD4 T cell counts >500 cells/μl, and no history of ART [27, 28] . Subsequently, loss of LTNP status was defined by any of the following events: a consistent decline in CD4 T cell counts below 500/μl, commencement of ART, and after viral load testing became routine, plasma viraemia >5000 copies/ml. Elite non-progressors were also defined by viraemia suppressed to <50 copies/ ml in addition to the above criteria. Disease progression was defined by a CD4 T cell count of <200 and/or plasma viraemia >100,000 copies/ml.
 
  Search related documents: 
                                Co phrase  search for related documents- cell count and Disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
  - cell count and elite non progressor: 1
  - cell count and load testing: 1
  - cell count and non progressor: 1
  - cell count and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
  - cell count and TAHIV cohort: 1
  - cell count and viral load testing: 1
  - consistent decline and Disease progression: 1
  - criterion addition and prospective study: 1, 2
  - Disease progression and elite non progressor: 1
  - Disease progression and follow event: 1, 2
  - Disease progression and LTNP status: 1, 2, 3
  - Disease progression and LTNP status loss: 1, 2, 3
  - Disease progression and non progressor: 1, 2, 3, 4, 5
  - Disease progression and NSW TAHIV cohort: 1
  - Disease progression and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
  - Disease progression and TAHIV cohort: 1, 2
  - elite non progressor and non progressor: 1
  - elite non progressor and TAHIV cohort: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date